Overview
To determine the effect of neurocognitive therapy with and without a soft robotic hand on manual ability, dexterity, strength, spasticity and upper limb function in sub-acute stroke.
Description
Stroke is a global disease with high death rate and high disability caused by motor cortical damage. According to the calculations, there were approximately 13.68 million new increased stroke patients all over the world a year and about 70% of survivors had different degrees of upper limb and hand movement dysfunction .The recovery rate of patients' motor function mainly depends on rehabilitation training. Therefore, due to individual difference of patients. Neurocognitive therapy is an effective therapy to improve and increase cognitive, sensory and motor function of upper limb. Robotic hand also help the function of weak hand muscle. Neurocognitive therapy with a robotic hand will have the potential to offer targeted, precise, and adaptable interventions, possibly increase the rehabilitation process compared to both interventions alone. Evaluating their relative efficacy will aid in refining and tailoring rehabilitation strategies for individuals recovering from acute stroke.
Eligibility
Inclusion Criteria:
- Participants of Post stroke patients (6-12 weeks )
- Participants with Spasticity < 2 on modified Ashworth scale.
- Participants with first ever stroke.
- Participants with normal cognition > 24 on MoCA
- Participants must be able to provide informed consent
- Hemiparesis with arm motor deficit as assessed by with NIHSS >1(14)
Exclusion Criteria:
- Participants who have a history of significant neurological or orthopedic disorders, other than stroke, that could interfere with upper limb motor or sensory recovery.
- Participants who have altered state of consciousness, severe aphasia, severe cognitive deficit.
- Participants who have severe pathologies of traumatic and or rheumatic nature, severe pain in effected arm (>5 on visual analog scale for pain) .
- Participants who have active pacemakers and other active implants.